Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & Research SupplyReagents, PPE & instruments — chain-of-custody documented.Fast, traceable sourcing built for regulated research environments, from bench consumables to instrumentation.Shop lac.us CodeCASRAIlac.us

Startup Equipment Financing: Leases, Loans, and SBA Options for Lab Instruments

How university spinouts and early-stage biotech founders finance lab equipment without draining seed capital: leases, loans, SBA 7(a)/504, venture debt, and how to evaluate offers and vendors.

Ask about Startup Equipment Financing: Leases, Loans, and SBA Options for Lab Instruments

Answers are drawn from this guide and the rest of the CASRAI corpus, with a link to every source.

Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this

Founders launching a university spinout or early-stage biotech company routinely hit the same wall early: a functioning lab needs a freeze-dryer, an HPLC, a benchtop sequencer or a cell-imaging system, and each of those can cost as much as a year of seed capital. Financing that equipment — rather than paying cash from a scarce seed round — is one of the most consequential early capital-allocation decisions a founding team makes, and one that most first-time founders have never had to evaluate before. This guide covers the real financing mechanisms available for startup lab equipment, how to evaluate an offer on its actual economics, and how equipment financing interacts with grant funding, the cap table, and vendor selection.

Why this decision is different for a research startup

Equipment financing decisions for a biotech or deep-tech spinout differ from a typical small-business equipment purchase in three ways that should shape how you evaluate options:

  • Capital efficiency is existential. Seed and pre-seed rounds are usually sized around 12–18 months of runway. A $150,000 cash purchase of a single instrument can consume a meaningful share of that runway before the company has generated any data to support the next raise.
  • Equipment is often specialized and illiquid. Lab instruments have a much thinner resale market than, say, office or restaurant equipment, which affects the residual value a lessor will underwrite and the loan-to-value a lender will offer.
  • The company may have non-dilutive funding streams a typical small business doesn’t — SBIR/STTR awards, university proof-of-concept or gap funds, and (for university-affiliated spinouts) in-kind access to shared instrumentation cores — which should be weighed against every financed or purchased option before committing capital or debt.

See Funding Options for a University Spinout for how equipment financing fits alongside SBIR/STTR, gap funds, licensing income, and venture capital in an early-stage capital stack, and Entrepreneurial Resources for University Spinouts and Faculty Founders for the broader landscape of TTO-adjacent startup support.

The main financing mechanisms, compared

Operating lease

The lessor retains ownership; you pay for the use of the equipment over a fixed term, and at the end of the term the equipment is returned, renewed, or purchased at fair market value. Monthly payments are typically lower than a finance lease or loan because you aren’t paying down the full asset price, and under U.S. GAAP (ASC 842) an operating lease still creates a right-of-use asset and lease liability on the balance sheet, but the expense profile and classification differ from a finance lease. This is usually the best fit for instruments that update quickly (sequencers, imaging systems) where you don’t want to own an asset that’s obsolete in three years.

Finance lease (capital lease) / equipment loan

Structured so that ownership effectively transfers to you at the end of the term (often for a nominal $1 buyout), a finance lease behaves economically like a loan secured by the equipment itself. Equipment loans work the same way without the lease structure: a lender advances funds (often up to 80–100% of the purchase price) secured by a lien on the instrument, and you own it from day one. Both are generally a better fit than an operating lease when you expect to use the instrument for its full useful life and want the depreciation and (where eligible) Section 179 or bonus-depreciation tax treatment.

Vendor/manufacturer financing

Many instrument manufacturers and distributors offer in-house financing or a captive-finance-arm lease/loan at the point of sale, sometimes bundled with a service contract. This can simplify procurement into a single transaction, but compare the effective rate and total cost against an independent lender or lessor before accepting a vendor’s financing as the default — convenience financing is not always the cheapest financing.

SBA 7(a) and SBA 504 loans

U.S. Small Business Administration-guaranteed loans are available to qualifying small businesses, including many early-stage life-science and deep-tech companies, and can be used to purchase lab equipment. The general-purpose 7(a) program can finance equipment alongside working capital and other business needs. The 504 program is specifically structured for major fixed assets with a longer useful life, typically combining a conventional lender loan, a Certified Development Company (CDC) debenture backed by an SBA guarantee, and a borrower down payment, resulting in longer terms and often more favorable fixed rates than a conventional equipment loan. SBA-backed financing generally requires the business to meet SBA size standards and to demonstrate repayment capacity, which can be a real constraint for a pre-revenue spinout — confirm current eligibility, guarantee percentages, and loan limits directly with an SBA-participating lender or the SBA, since program parameters are adjusted periodically.

Venture debt

For startups that have already raised an institutional equity round, venture debt lenders will sometimes structure equipment-specific tranches (or a general growth-capital facility that includes equipment) alongside warrants, rather than requiring the equipment itself as the sole security. This is rarely available pre-seed or pre-Series-A and typically requires an existing institutional investor syndicate.

Non-dilutive and in-kind alternatives

Before financing anything, check whether the need can be met without a lease or loan at all: SBIR/STTR Phase I/II awards can often be budgeted to cover equipment directly tied to the funded research; some universities operate equipment gap funds or evergreen funds for affiliated spinouts (see University Evergreen and Spinout Funds); and shared instrumentation cores or fee-for-service facilities can substitute for ownership entirely during the earliest, lowest-throughput stage of a company’s life.

How to evaluate a financing offer

Compare offers on these dimensions, not just the headline monthly payment:

  • Total cost of capital. Ask for the effective annual rate or factor rate, not just the payment amount — a lower monthly payment stretched over a longer term can cost significantly more in total.
  • Term length vs. useful life. A term that outlasts the equipment’s realistic useful life (or your realistic use case, given how fast some instrument categories iterate) leaves you paying for an asset you’ve already replaced.
  • End-of-term terms. Fair-market-value buyout, fixed $1 buyout, or mandatory return — each has different balance-sheet and cash-flow implications, and mandatory-return terms can include end-of-lease refurbishment or shipping obligations that are easy to overlook at signing.
  • Personal guarantees and covenants. Many early-stage equipment loans and some leases require a personal guarantee from founders and/or financial covenants (minimum cash runway, reporting requirements) — understand exactly what’s being pledged before signing.
  • Prepayment and early-termination terms. If the company might be acquired, pivot, or need to return equipment early, check for prepayment penalties or early-termination fees.
  • Tax treatment. Purchased equipment (including equipment bought via a finance lease or loan) may qualify for Section 179 expensing or bonus depreciation in the year it’s placed in service, subject to annual dollar caps and phase-out thresholds that change from year to year — confirm current-year limits with a tax advisor before assuming a specific deduction amount, since this is not a figure to rely on from a general guide.
  • Balance-sheet and dilution impact. Debt and lease obligations show up as liabilities and can affect covenants in a future equity or venture-debt round; weigh that against the dilution cost of instead raising additional equity to buy equipment in cash.

Evaluating the vendor, not just the financing

The financing terms only matter if the underlying instrument and vendor relationship hold up. When comparing suppliers — whether buying new, refurbished, or through a distributor offering a financed package — evaluate:

  • Calibration and accreditation documentation. For instruments feeding into regulated or publication-grade data, confirm the vendor can provide a valid calibration certificate traceable to a recognized standard, and check whether the vendor’s service organization holds relevant accreditation (for example, ISO/IEC 17025 for calibration and testing laboratories) rather than taking a “certified” claim at face value.
  • Warranty and service-contract scope. Confirm what’s covered, for how long, and whether service is performed by the manufacturer, an authorized third party, or the financing company’s own technicians.
  • Refurbished-equipment provenance. If considering refurbished instrumentation to reduce cost, ask for documented service and calibration history, not just a visual “as-new” condition claim. Distributors that specialize in laboratory and medical equipment — for example LAC Health (lac.us), which supplies new and refurbished lab and medical equipment to research and clinical customers — are one channel through which this documentation is typically available; evaluate any such distributor on the same accreditation, warranty, and calibration-documentation criteria as any other vendor rather than on reputation alone.
  • Total lead time. Financing approval and equipment lead time run on separate clocks; a fast credit decision doesn’t help if the instrument itself has a six-month backorder.

If federal grant funds are involved

Everything above applies to equipment a company finances or purchases with its own capital or private debt. If the equipment will instead be purchased with federal grant or contract funds — for example under an SBIR/STTR award or a federal research grant — a different rulebook applies: 2 CFR 200.465 governs how rental and lease costs are allowed on federal awards, and separate federal equipment-management and titling rules apply to equipment purchased outright with award funds (see Equipment Titling and Conditional Title on Federal Awards). Don’t assume private-market financing terms and federal-award cost-allowability rules can be mixed on the same purchase without checking which funding source is actually paying for the instrument.

Practical checklist before signing

  1. Confirm whether a non-dilutive or in-kind alternative (SBIR budget line, gap fund, shared core) could meet the need first.
  2. Get at least two financing quotes (a lease and a loan, or two lenders) so you have a real comparison point on effective rate, not just payment.
  3. Match the financing term to the instrument’s realistic useful life for your application.
  4. Read the personal-guarantee and covenant language before signing, not after.
  5. Separately verify the vendor’s calibration/accreditation documentation and warranty terms.
  6. If any portion of the purchase touches federal award funds, confirm allowability and titling treatment with your sponsored-programs office before committing.

Frequently asked questions

Can a pre-revenue startup get equipment financing?

It’s possible but harder: pre-revenue companies typically face higher rates, may need a personal guarantee from founders, and may be limited to vendor financing or smaller equipment-loan amounts rather than the largest SBA or venture-debt facilities, which generally expect some revenue history or institutional equity backing. Non-dilutive routes (SBIR budget lines, university gap funds) are often more accessible pre-revenue than debt financing.

Is leasing or buying better for a biotech startup’s lab equipment?

It depends on how quickly the instrument category changes and how confident you are in the useful life. Fast-iterating categories (sequencing, imaging) often favor a lease with an upgrade path; stable, long-life equipment you’ll use for years often favors a loan or finance lease where you capture the tax and ownership benefits. Run the total-cost-of-capital comparison in this guide rather than defaulting to either option.

Does SBA financing actually cover laboratory equipment?

Yes — both SBA 7(a) and 504 loans can finance equipment purchases for qualifying small businesses, including many life-science and deep-tech startups, subject to standard SBA size-standard and use-of-proceeds rules. Confirm current program terms with an SBA-participating lender, since guarantee percentages and loan limits are adjusted periodically.

Does equipment financing affect a startup’s cap table?

Debt-based equipment financing (loans, finance leases, most operating leases) does not directly dilute equity the way raising an equity round does, but it does add to the company’s liabilities and can affect covenants or terms in a subsequent equity or venture-debt raise. Some vendor or venture-debt financing includes warrants, which is a form of minor, targeted dilution — read the term sheet carefully to see whether warrants are attached.

What credit history do investors and lenders expect from a new spinout?

Because a newly formed spinout has no independent credit history, lenders typically underwrite based on the founders’ personal credit, any institutional funding already raised, grant awards in hand, and university or accelerator affiliation, rather than the company’s own trading history. This is one reason personal guarantees are common in early-stage equipment financing.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →